drugset / Trial / NCT00032708

Dryvax Dilution-Prev Vacc Adults

NCT00032708

RandomizedParallel-groupDouble-blindPrevention

Summary

A double-blind, randomized, dose-response study of four dilutions of Dryvax in previously vaccinated adults in order to assess the clinical success rates, humoral responses, and virus-specific actifity of cytotoxi T cells and interferon-y producing T cells

Timeline

Start
2004-04
Primary completion
Completion
2004-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Dryvax Vaccine

Indications